Endpoints News – Biotech and pharma business news, with a focus …
A decade after Bristol Myers Squibb first won approval for its PD-1 checkpoint inhibitor Opdivo, the cancer drug has been approved in a subcutaneous form that's becom ...
Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather …
FDA spells out expedited withdrawal process for accelerated …
Dec 5, 2024 · The FDA on Thursday released new details on how it plans to expedite the withdrawal of certain accelerated approvals when drugs fail to show clinical benefit in …
Big dreams dominate among next-gen biotech players
Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. Here’s John Carroll’s top picks for the next-gen players …
News – Endpoints News
reset password. We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email
The Endpoints 100 survey: What are biopharma execs saying …
Dec 11, 2024 · We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes …
New Trump era could be a boon for biopharma M&A, dealmaking
Nov 6, 2024 · As former President Donald Trump returns to power — the Associated Press projected his presidential victory Wednesday morning — the biopharma indus ...
Endpoints Careers - Find your next biopharma job
New benefit for Enterprise subscribers. All companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge.Contact your …
Special report 2024: Meet 20 women breaking new ground in …
Oct 7, 2024 · Dedicated to the memory of Natalie Grover, who co-created the Women in Biopharma R&D special report while she was a reporter at Endpoints from 2018-2020. Natalie …
Endpoints at #BIO23: The dawn of a new biotech era
The dawn of a new biotech era. The biotech industry’s annual trade conference is back in Boston. We assess where we are as an industry and break down the future trends in biopharma.